{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T18:31:50Z","timestamp":1791570710857,"version":"4.3.4"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T00:00:00Z","timestamp":1717027200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence Reports"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.dadr.2024.100247","type":"journal-article","created":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T11:18:44Z","timestamp":1717586324000},"page":"100247","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Xylazine awareness, desire, use and exposure: Preliminary findings from the Rhode Island community-based drug checking cohort study"],"prefix":"10.1016","volume":"11","author":[{"given":"Ju Nyeong","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Serafinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merci","family":"Ujeneza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"McKenzie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Tardif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex J.","family":"Krotulski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adina","family":"Badea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elyse R.","family":"Grossman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Traci C.","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.dadr.2024.100247_bib1","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.2105\/AJPH.2022.306881","article-title":"Xylazine and overdoses: trends, concerns, and recommendations","volume":"112","author":"Alexander","year":"2022","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.dadr.2024.100247_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2023.104086","article-title":"Drug checking in the fentanyl era: utilization and interest among people who inject drugs in San Diego, California","volume":"118","author":"Bailey","year":"2023","journal-title":"Int J. Drug Policy"},{"key":"10.1016\/j.dadr.2024.100247_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2023.04.009","article-title":"Skin ulcerations caused by xylazine: a lesser-known entity","author":"Bishnoi","year":"2023","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.dadr.2024.100247_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2020.102695","article-title":"The protective effect of trusted dealers against opioid overdose in the US.","volume":"78","author":"Carroll","year":"2020","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.dadr.2024.100247_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2023.111028","article-title":"Costing analysis of a point-of-care drug checking program in Rhode Island","volume":"253","author":"Cepeda","year":"2023","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.dadr.2024.100247_bib6","unstructured":"CFSRE).(2022) Evaluation of xylazine test strips (BTNX) for drug checking purposes. \u3008https:\/\/www.cfsre.org\/images\/content\/reports\/drug_checking\/Evaluation_of_BTNX_Xylazine_Test_Strips_for_Drug_Checking_230322.pdf\u3009"},{"key":"10.1016\/j.dadr.2024.100247_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2023.104118","article-title":"Comprehensive testing and rapid dissemination of local drug supply surveillance data in Rhode Island","volume":"118","author":"Collins","year":"2023","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.dadr.2024.100247_bib8","unstructured":"Green, T., Hughto, J., Ruiz, S.Rapid Assessment of Consumer Knowledge (RACK). 2021a(March 3, 2021). \u3008https:\/\/heller.brandeis.edu\/opioid-policy\/community-resources\/index.html\u3009."},{"issue":"3","key":"10.1016\/j.dadr.2024.100247_bib9","first-page":"22","article-title":"COBRE on opioid and overdose: a collaborative research-based center addressing the crises in rhode island and beyond","volume":"104","author":"Green","year":"2021","journal-title":"Rhode Isl. Med. J."},{"issue":"1","key":"10.1016\/j.dadr.2024.100247_bib10","doi-asserted-by":"crossref","first-page":"S347","DOI":"10.1097\/PHH.0000000000001581","article-title":"Implementation and Uptake of the Massachusetts Drug Supply Data Stream: a statewide public health-public safety partnership drug checking program","volume":"28","author":"Green","year":"2022","journal-title":"J. Public Health Manag. Pract."},{"key":"10.1016\/j.dadr.2024.100247_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2020.102661","article-title":"An assessment of the limits of detection, sensitivity and specificity of three devices for public health-based drug checking of fentanyl in street-acquired samples","volume":"77","author":"Green","year":"2020","journal-title":"Int. J. Drug Policy"},{"issue":"24","key":"10.1016\/j.dadr.2024.100247_bib12","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMp2303120","article-title":"Xylazine - Medical and Public Health Imperatives","volume":"388","author":"Gupta","year":"2023","journal-title":"N. Engl. J. Med"},{"issue":"1","key":"10.1016\/j.dadr.2024.100247_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12954-017-0179-5","article-title":"An overview of forensic drug testing methods and their suitability for harm reduction point-of-care services","volume":"14","author":"Harper","year":"2017","journal-title":"Harm Reduct. J."},{"issue":"1","key":"10.1016\/j.dadr.2024.100247_bib14","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13011-023-00538-x","article-title":"Drug use patterns and factors related to the use and discontinuation of medications for opioid use disorder in the age of fentanyl: findings from a mixed-methods study of people who use drugs","volume":"18","author":"Hughto","year":"2023","journal-title":"Subst. Abus. Treat., Prev., Policy"},{"key":"10.1016\/j.dadr.2024.100247_bib15","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1136\/injuryprev-2020-043968","article-title":"Increasing presence of xylazine in heroin and\/or fentanyl deaths, Philadelphia, Pennsylvania, 2010\u20132019","volume":"27","author":"Johnson","year":"2021","journal-title":"Inj. Prev."},{"key":"10.1016\/j.dadr.2024.100247_bib16","unstructured":"Joint Economic Committee (JEC). The economic toll of the opioid crisis reached nearly $1.5 trillion in 2020. \u3008https:\/\/www.jec.senate.gov\/public\/index.cfm\/democrats\/2022\/9\/the-economic-toll-of-the-opioid-crisis-reached-nearly-1-5-trillion-in-2020\u3009. Retrieved 10\/3\/23.(2022)"},{"issue":"26","key":"10.1016\/j.dadr.2024.100247_bib17","doi-asserted-by":"crossref","first-page":"721","DOI":"10.15585\/mmwr.mm7226a4","article-title":"Illicitly manufactured fentanyl-involved overdose deaths with detected xylazine - United States, January 2019-June 2022","volume":"72","author":"Kariisa","year":"2023","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"issue":"37","key":"10.1016\/j.dadr.2024.100247_bib18","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.15585\/mmwr.mm7037a4","article-title":"Xylazine detection and involvement in drug overdose deaths - United States, 2019","volume":"70","author":"Kariisa","year":"2021","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"10.1016\/j.dadr.2024.100247_bib19","unstructured":"Legislative Analysis and Public Policy Association. The Model Fentanyl\/Xylazine Test Strip and Other Drug Checking Equipment Act. April 2023. Washington D.C., USA. \u3008https:\/\/legislativeanalysis.org\/wp-content\/uploads\/2023\/12\/Model-Fentanyl-Xylazine-Test-Strip-and-Other-Drug-Checking-Equipment-Act.pdf\u3009"},{"issue":"3","key":"10.1016\/j.dadr.2024.100247_bib20","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/add.15734","article-title":"Drug checking services for people who use drugs: a systematic review","volume":"117","author":"Maghsoudi","year":"2022","journal-title":"Addiction"},{"key":"10.1016\/j.dadr.2024.100247_bib21","unstructured":"Massachusetts Drug Supply Data Stream (MADDS). (2024) Brandeis University. Accessed 2\/8\/24. \u3008https:\/\/heller.brandeis.edu\/opioid-policy\/community-resources\/madds\/drug-checking-resources.html\u3009"},{"key":"10.1016\/j.dadr.2024.100247_bib22","unstructured":"McCrae, Tobias, Stunden(2022). Drug Checking Operational Technician Manual Version 2. British Columbia Centre on Substance Use. Vancouver, Canada.."},{"issue":"3","key":"10.1016\/j.dadr.2024.100247_bib23","doi-asserted-by":"crossref","first-page":"276","DOI":"10.11613\/BM.2012.031","article-title":"Interrater reliability: the kappa statistic","volume":"22","author":"McHugh","year":"2012","journal-title":"Biochem. Med."},{"issue":"4","key":"10.1016\/j.dadr.2024.100247_bib24","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/YCO.0000000000000607","article-title":"Drug checking to detect fentanyl and new psychoactive substances","volume":"33","author":"Palamar","year":"2020","journal-title":"Curr. Opin. Psychiatry"},{"key":"10.1016\/j.dadr.2024.100247_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2021.103196","article-title":"Evaluation of fentanyl test strip distribution in two Mid-Atlantic syringe services programs","volume":"94","author":"Park","year":"2021","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.dadr.2024.100247_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2023.104206","article-title":"A survey of North American drug checking services operating in 2022","volume":"121","author":"Park","year":"2023","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.dadr.2024.100247_bib27","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.drugpo.2018.08.007","article-title":"Fentanyl test strips as an opioid overdose prevention strategy: findings from a syringe services program in the Southeastern United States","volume":"63","author":"Peiper","year":"2019","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.dadr.2024.100247_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.forsciint.2014.03.015","article-title":"Xylazine intoxication in humans and its importance as an emerging adulterant in abused drugs: a comprehensive review of the literature","volume":"240","author":"Ruiz-Col\u00f3n","year":"2014","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.dadr.2024.100247_bib29","doi-asserted-by":"crossref","DOI":"10.15585\/mmwr.mm7217a2","article-title":"Rapid analysis of drugs: a pilot surveillance system to detect changes in the illicit drug supply to guide timely harm reduction responses\u2014eight syringe services programs, Maryland, November 2021\u2013August 2022","volume":"72","author":"Russell","year":"2023","journal-title":"Mmwr. Morb. Mortal. Wkly. Report."},{"key":"10.1016\/j.dadr.2024.100247_bib30","doi-asserted-by":"crossref","unstructured":"Spencer M.R., Garnett M.F., Mini\u00f1o A.M. Drug overdose deaths in the United States, 2002\u20132022. NCHS Data Brief, no 491. Hyattsville, MD: National Center for Health Statistics. 2024. doi: \u3008https:\/\/dx.doi.org\/10.15620\/cdc:135849\u3009","DOI":"10.15620\/cdc:135849"},{"key":"10.1016\/j.dadr.2024.100247_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108006","article-title":"Detecting fentanyl using point-of-care drug checking technologies: a validation study","volume":"212","author":"Ti","year":"2020","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.dadr.2024.100247_bib32","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s12954-023-00879-7","article-title":"Reducing the harms of xylazine: clinical approaches, research deficits, and public health context","volume":"20","author":"Zagorski","year":"2023","journal-title":"Harm Reduct. J."}],"container-title":["Drug and Alcohol Dependence Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772724624000313?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772724624000313?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T03:14:17Z","timestamp":1718853257000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772724624000313"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":32,"alternative-id":["S2772724624000313"],"URL":"https:\/\/doi.org\/10.1016\/j.dadr.2024.100247","relation":{},"ISSN":["2772-7246"],"issn-type":[{"value":"2772-7246","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Xylazine awareness, desire, use and exposure: Preliminary findings from the Rhode Island community-based drug checking cohort study","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dadr.2024.100247","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100247"}}